Bladder Cancer

In North America, bladder cancer is the fourth most common cancer in men and in the top ten for women. In the United States, approximately 70,000 patients are newly diagnosed with bladder cancer each year.
What is Bladder Cancer?

Bladder cancer refers to the growth of a tumor within the lining of the bladder. In some cases, the tumor can invade surrounding tissue and spread to other parts of the body.

Read More

Overview

Feature Articles

Latest Bladder Cancer News and Research

Simple urine test halves cystoscopy procedures for bladder cancer patients

Simple urine test halves cystoscopy procedures for bladder cancer patients

Blood-based DNA test spares bladder cancer patients from unnecessary treatments

Blood-based DNA test spares bladder cancer patients from unnecessary treatments

Lancet Commission predicts sharp increase in global prostate cancer cases

Lancet Commission predicts sharp increase in global prostate cancer cases

Using microbiota analysis for health and disease management

Using microbiota analysis for health and disease management

New battery-free implant allows users to monitor their bladder fullness in real time

New battery-free implant allows users to monitor their bladder fullness in real time

New insights into upper tract urothelial carcinoma evolution and treatment

New insights into upper tract urothelial carcinoma evolution and treatment

NCCN updates treatment guidelines for high-incidence cancers

NCCN updates treatment guidelines for high-incidence cancers

Mediterranean diet linked to richer gut diversity, study finds

Mediterranean diet linked to richer gut diversity, study finds

Developing a prognostic model for bladder urothelial cancer using oxidative stress signatures

Developing a prognostic model for bladder urothelial cancer using oxidative stress signatures

Study links specific inflammatory markers to increased cancer risk

Study links specific inflammatory markers to increased cancer risk

Bio-Techne’s Advanced Cell Diagnostics (ACD) sets new standard in spatial biology with protease-free RNAscope multiomics

Bio-Techne’s Advanced Cell Diagnostics (ACD) sets new standard in spatial biology with protease-free RNAscope multiomics

A certain type of chemotherapy found to improve the immune system's ability to fight off bladder cancer

A certain type of chemotherapy found to improve the immune system's ability to fight off bladder cancer

Immunotherapy breakthrough: Pembrolizumab extends time to recurrence in aggressive bladder cancer

Immunotherapy breakthrough: Pembrolizumab extends time to recurrence in aggressive bladder cancer

Urea-powered nanorobots reduce bladder tumors by 90% in mice

Urea-powered nanorobots reduce bladder tumors by 90% in mice

Nanobots for bladder cancer treatment, promising high efficacy and targeted delivery

Nanobots for bladder cancer treatment, promising high efficacy and targeted delivery

New inhibitor shows promise in combating advanced prostate cancer

New inhibitor shows promise in combating advanced prostate cancer

New $3.2 million grant fuels collaborative fight against cancers

New $3.2 million grant fuels collaborative fight against cancers

Study: Risk of dying from cancer depends on where you live in England

Study: Risk of dying from cancer depends on where you live in England

New artificial intelligence algorithms facilitate diagnosis of difficult cancers

New artificial intelligence algorithms facilitate diagnosis of difficult cancers

Novel urine-based prognostic model promises to transform bladder cancer treatment

Novel urine-based prognostic model promises to transform bladder cancer treatment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.